UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development

American journal of human genetics, 2019-05, Vol.104 (5), p.985-989

2019

Volltextzugriff (PDF)

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

Cell transplantation, 2022, Vol.31, p.9636897221096160-9636897221096160

2022

Volltextzugriff (PDF)

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

PloS one, 2008-06, Vol.3 (6), p.e2435-e2435

2008

Volltextzugriff (PDF)

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients

Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2267-2276

2009

Volltextzugriff (PDF)

Comparative evaluation of simple indices of graft function after islet transplantation

Transplantation, 2011-10, Vol.92 (7), p.815

2011

Volltextzugriff (PDF)

Foxp3 expression is required for the induction of therapeutic tissue tolerance

The Journal of immunology (1950), 2012-10, Vol.189 (8), p.3947-3956

2012

Volltextzugriff (PDF)

Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report

BMC medical genetics, 2017-05, Vol.18 (1), p.57-57, Article 57

2017

Volltextzugriff (PDF)

Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus

Frontiers in pediatrics, 2021-02, Vol.9, p.624416-624416

2021

Volltextzugriff (PDF)

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

The Lancet (British edition), 2021-06, Vol.397 (10291), p.2275-2283

2021

Volltextzugriff (PDF)

Harnessing FOXP3+ regulatory T cells for transplantation tolerance

The Journal of clinical investigation, 2014-04, Vol.124 (4), p.1439-1445

2014

Volltextzugriff (PDF)

Comparing youth with and without type 1 diabetes on perceived parenting and peer functioning: a propensity weighting approach

Journal of behavioral medicine, 2023-12, Vol.46 (6), p.1032-1041

2023

Volltextzugriff (PDF)

Acid-base and electrolyte disturbances in patients with diabetes mellitus

Acta clinica belgica (English ed. Online), 2019-01, Vol.74 (1), p.28-33

2019

Volltextzugriff (PDF)

Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial

The lancet. Diabetes & endocrinology, 2023-02, Vol.11 (2), p.96-108

2023

Volltextzugriff (PDF)

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Diabetologia, 2021-02, Vol.64 (2), p.313-324

2021

Volltextzugriff (PDF)

The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial

Journal of diabetes science and technology, 2024-05, Vol.18 (3), p.660-666

2024

Volltextzugriff (PDF)

Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients

American journal of transplantation, 2022-03, Vol.22 (3), p.927-936

2022

Volltextzugriff (PDF)

646-P: Sustained Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring in Adults with Type 1Diabetes: 24-Month Results of the ALERTT1 Trial

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients

Transplantation, 2020-10, Vol.104 (10), p.e295

2020

Volltextzugriff (PDF)

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Transplant international, 2021-07, Vol.34 (7), p.1182-1186

2021

Volltextzugriff (PDF)

Formation of amyloid in encapsulated human pancreatic and human stem cell‐generated beta cell implants

American journal of transplantation, 2021-06, Vol.21 (6), p.2090-2099

2021

Volltextzugriff (PDF)

Harnessing FOXP3 super( +) regulatory T cells for transplantation tolerance

The Journal of clinical investigation, 2014-04, Vol.124 (4), p.1439-1439

2014

Volltextzugriff (PDF)

Harnessing FOXP3^sup +^ regulatory T cells for transplantation tolerance

The Journal of clinical investigation, 2014-04, Vol.124 (4), p.1439

2014

Volltextzugriff (PDF)

Regulatory T cells and transplantation tolerance

Immunotherapy, 2013-07, Vol.5 (7), p.717-731

2013

Volltextzugriff (PDF)

Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression

Transplantation, 2017-09, Vol.101 (9), p.2218

2017

Volltextzugriff (PDF)

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

Diabetes care, 2013-11, Vol.36 (11), p.3483-3488

2013

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Transplantation
(9)
Diabetes Care
(4)
The Journal Of Clinical Investigation
(3)
American Journal Of Transplantation
(2)
Diabetes
(2)
Diabetologia
(2)
Plos One
(2)
The Journal Of Immunology
(2)
The Lancet
(2)
Acta Clinica Belgica
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients

Comparative evaluation of simple indices of graft function after islet transplantation

Foxp3 expression is required for the induction of therapeutic tissue tolerance

Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report

Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

Harnessing FOXP3+ regulatory T cells for transplantation tolerance

Comparing youth with and without type 1 diabetes on perceived parenting and peer functioning: a propensity weighting approach

Acid-base and electrolyte disturbances in patients with diabetes mellitus

Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial

Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients

646-P: Sustained Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring in Adults with Type 1Diabetes: 24-Month Results of the ALERTT1 Trial

Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Formation of amyloid in encapsulated human pancreatic and human stem cell‐generated beta cell implants

Harnessing FOXP3 super( +) regulatory T cells for transplantation tolerance

Harnessing FOXP3^sup +^ regulatory T cells for transplantation tolerance

Regulatory T cells and transplantation tolerance

Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

Suchergebnisse filtern